Strategic product control Proliant uniquely controls the entire BSA supply chain from collection to processing, enabling high-quality, consistent animal-derived protein products. This positions the company well for customers seeking reliable raw materials for diagnostics, biopharmaceuticals, and cell culture applications, suggesting a sales focus on premium BSA contracts, custom-grade requirements, and traceability solutions.

Recombinant opportunity Recent launch of recombinant human albumin in partnership with Dyadic Applied BioSolutions expands the product portfolio into recombinant proteins. This presents growth potential with biopharma and research accounts seeking scalable, human-protein materials and could be leveraged to cross-sell BSA and cell culture media components as complementary offerings.

Cell culture expansion Introduction of high-quality cell culture media components aligns with rising demand in diagnostics, biopharmaceuticals, and research across global markets. Sales opportunities include bundled media component suites, custom media formulations, and regulatory-compliant sourcing for cell culture workflows.

Global market positioning As a niche but scalable supplier with a focus on traceability and end-to-end processing, Proliant can target mid-to-large biotech firms and contract manufacturers seeking reliable, compliant raw materials. Emphasize stability, quality control, and supply security in outreach to ensure differentiation from larger competitors.

Tech-enabled outreach Existing tech stack (Cloudflare, Shopify, forms) indicates readiness for streamlined e-commerce and digital engagement. Invest in targeted digital campaigns, responsive product pages for BSA and media components, and lead magnets (certifications, QA docs) to accelerate inbound inquiries and shorten sales cycles with research and development teams.